These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1807968)

  • 21. Power spectral electroencephalogram analysis of the effects of ritanserin in freely moving rats during quiet waking.
    Moyanova S; Kirov R; Ivanova V
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):605-11. PubMed ID: 9500124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.
    da Roza Davis JM; Sharpley AL; Cowen PJ
    Psychopharmacology (Berl); 1992; 108(3):387-9. PubMed ID: 1523288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
    da Roza Davis JM; Sharpley AL; Solomon RA; Cowen PJ
    J Affect Disord; 1992 Mar; 24(3):177-81. PubMed ID: 1573126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [5 HT2 antagonists and carpipramine].
    Sechter D; Loo H
    Rev Prat; 1990 Nov; 40(25):2363-5. PubMed ID: 2124722
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation by evoked potentials of attentional abilities in patients with depression under amoxapine or imipramine].
    el Massioui F
    Encephale; 1991 Dec; 17 Spec No 3():441-4. PubMed ID: 1807972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
    Idzikowski C; Mills FJ; Glennard R
    Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.
    Aslan S; Isik E; Cosar B
    Sleep; 2002 Sep; 25(6):677-9. PubMed ID: 12224847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central administration of a 5-HT2 receptor agonist and antagonist: lack of effect on rapid eye movement sleep and pgo waves.
    Sanford LD; Hunt WK; Ross RJ; Pack AI; Morrison AR
    Sleep Res Online; 1998; 1(2):80-6. PubMed ID: 11382861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):52-9. PubMed ID: 2746510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis.
    Solomon RA; Sharpley AL; Cowen PJ
    J Psychopharmacol; 1989 Jan; 3(3):125-9. PubMed ID: 22282895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin-induced increase in cAMP in ganglia isolated from the myenteric plexus of the guinea pig small intestine: mediation by a novel 5-HT receptor.
    Fiorica-Howells E; Wade PR; Gershon MD
    Synapse; 1993 Apr; 13(4):333-49. PubMed ID: 8386861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
    Adrien J
    J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.